Roivant Alternatives & Competitors
12 companies similar to Roivant — Reinventing Biopharma
Cullinan Therapeutics
Science That Moves
Cambridge, United States
Entelexo Biotherapeutics
Entelexo has created a novel platform technology for engineering exosomes as a new approac...
Irvine, United States
Adicet Bio, Inc
A biotechnology company discovering and developing first-in-class allogeneic gamma delta C...
Redwood City, United Stat...
Zenas BioPharma
Enabling patients with autoimmune diseases to reimagine life
Waltham, United States
Track all Roivant competitors
Get real-time alerts when any of these companies raise funding, hire, or show growth signals.
4D Molecular Therapeutics
Powering the Future of Genetic Medicines
Emeryville, United States
Autolus Therapeutics
Focused on the development of precisely targeted, controlled & highly active T cell therap...
London, United Kingdom
Cartesian Therapeutics
Cartesian | Developing potent, safer cell and gene therapies for cancer and autoimmune dis...
Mozart Therapeutics, Inc.
Orchestrating the Immune System
Seattle, United States
Immunocore
Science to Transform Lives
Abingdon, United Kingdom
ImageneBio
San Diego, United States
Io Therapeutics
Io therapeutics focuses on developing drugs that target nuclear receptors in order to trea...
Nkarta, Inc.
A New Way Forward for Autoimmune Disease
South San Francisco, Unit...
About Roivant
Reinventing Biopharma
Discovery and development of new medicines, Commercialization of pharmaceuticals, Clinical trials management, Establishment of specialized subsidiaries (Vants)
Patients with autoimmune diseases, Patients with pulmonary diseases, Healthcare professionals, Investors interested in biotechnology and pharmaceuticals, Regulatory bodies (e.g. FDA)
Biopharmaceutical Development, Innovative Medicines, Entrepreneurial Biotech, Disease Focused R&D, Uterine Fibroids, Endometriosis, Prostate Cancer, Parkinson’s Disease, Rare Pediatric Conditions, R&D Investment Gap, Technology Deployment, Drug Commercialization, Late-stage Drug Development, Healthcare System Efficiency
B2B, B2C, Platform
Product Sales, Licensing, Performance Based
Frequently Asked Questions
Don't just read about them. Follow them.
BounceWatch watches Roivant and millions of other companies. When one raises money, hires quickly or changes its product, we tell you the same day.
Compiled from the BounceWatch company index. We last looked at Roivant on 6 May 2026. The 12 companies listed here were last checked between 11 Mar 2026 and 22 Jun 2026. Where a field is blank here, it means we have not recorded it — not that the answer is zero. How we source and date this.